The estimated Net Worth of Mark Castaneda is at least $757 Tysiąc dollars as of 30 June 2024. Mark Castaneda owns over 8,375 units of Tilray Brands Inc stock worth over $276,060 and over the last 14 years Mark sold TLRY stock worth over $480,939.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mark Castaneda TLRY stock SEC Form 4 insiders trading
Mark has made over 21 trades of the Tilray Brands Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently Mark exercised 8,375 units of TLRY stock worth $14,405 on 30 June 2024.
The largest trade Mark's ever made was exercising 381,417 units of Tilray Brands Inc stock on 10 January 2018 worth over $656,037. On average, Mark trades about 21,042 units every 124 days since 2010. As of 30 June 2024 Mark still owns at least 160,500 units of Tilray Brands Inc stock.
You can see the complete history of Mark Castaneda stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Mark Castaneda's mailing address?
Mark's mailing address filed with the SEC is Red Hill Avenue, Costa Mesa, Orange County, California, 92626, United States.
Insiders trading at Tilray Brands Inc
Over the last 6 years, insiders at Tilray Brands Inc have traded over $92,844,538 worth of Tilray Brands Inc stock and bought 140,416 units worth $933,182 . The most active insiders traders include Irwin D Simon, Brendan Kennedy oraz Mitchell Gendel. On average, Tilray Brands Inc executives and independent directors trade stock every 13 days with the average trade being worth of $215,593. The most recent stock trade was executed by Irwin D Simon on 31 July 2024, trading 706,214 units of TLRY stock currently worth $1,433,614.
What does Tilray Brands Inc do?
tilray is a global leader in medical cannabis research and production dedicated to providing safe, consistent and reliable therapy to patients. we are the only gmp certified medical cannabis producer currently supplying products to thousands of patients, physicians, pharmacies, hospitals, governments and researchers in australia, canada, the european union and the americas.
What does Tilray Brands Inc's logo look like?
Complete history of Mark Castaneda stock trades at Primo Water, Gold Flora Corp oraz Tilray Brands Inc
Tilray Brands Inc executives and stock owners
Tilray Brands Inc executives and other stock owners filed with the SEC include:
-
Irwin David Simon,
Pres, CEO & Chairman -
Andrew Pucher,
Chief Corporate Development Officer -
Brendan Kennedy,
President, Chief Executive Officer, Director -
James R. Meiers,
Chief Operations Officer -
Denise Menikheim Faltischek,
Head of International & Chief Strategy Officer -
Carl A. Merton CA, CBV, CPA,
CFO & Principal Accounting Officer -
Katy Dickson,
President, Manitoba Harvest USA, LLC -
Katie Turner,
IR Contact Officer -
Christine St.Clare,
Independent Director -
Soren Schroder,
Independent Director -
Rebekah Dopp,
Independent Director -
Michael Auerbach,
Independent Director -
Jon Levin,
Chief Operating Officer -
Michael Kruteck,
Chief Financial Officer -
Mitch Gendell,
Global Gen. Counsel & Corp. Sec. -
Roger Savell,
Chief Admin. Officer -
Rita Seguin,
Chief HR Officer -
Bernard Yeung,
Sr. VP of Sales & Marketing -
Mitch Gendel,
Global Gen. Counsel & Corp. Sec. -
Dara Redler,
Interim Chief Legal Officer & Corp. Sec. -
John B. Sadler,
VP of Investor Relations -
Lloyd Brathwaite,
Chief Information Officer -
Maryscott Greenwood,
Director -
Edward Wood Jr Pastorius,
Chief Revenue Officer -
Mark Castaneda,
CFO, Secretary, Treasurer -
Kathryn P Dickson,
President- Manitoba Harvest -
Renah Persofsky,
Director -
Johann Michael Herhalt,
Director -
James R. Meiers,
Chief Operations Officer -
David F Clanachan,
Director -
Denise M Faltischek,
Chief Strategy Officer -
Mitchell Gendel,
Global General Counsel -
Carl A Merton,
Chief Financial Officer -
David G. Hopkinson,
Director -
Walter E Iv Robb,
Director -
Thomas P. Looney,
Director -
Jodi L. Butts,
Director -
Irwin D Simon,
President and CEO